scholarly journals Copy-Number Variation of the Glucose Transporter Gene SLC2A3 and Congenital Heart Defects in the 22q11.2 Deletion Syndrome

2015 ◽  
Vol 96 (5) ◽  
pp. 753-764 ◽  
Author(s):  
Elisabeth E. Mlynarski ◽  
Molly B. Sheridan ◽  
Michael Xie ◽  
Tingwei Guo ◽  
Silvia E. Racedo ◽  
...  
2016 ◽  
Vol 135 (3) ◽  
pp. 273-285 ◽  
Author(s):  
Elisabeth E. Mlynarski ◽  
◽  
Michael Xie ◽  
Deanne Taylor ◽  
Molly B. Sheridan ◽  
...  

2016 ◽  
Vol 175 ◽  
pp. 116-122.e4 ◽  
Author(s):  
Niels B. Matthiesen ◽  
Peter Agergaard ◽  
Tine B. Henriksen ◽  
Cathrine C. Bach ◽  
J. William Gaynor ◽  
...  

Author(s):  
Rafael Fabiano Machado Rosa ◽  
Patrícia Trevisan ◽  
Dayane Bohn Koshiyama ◽  
Carlo Benatti Pilla ◽  
Paulo Ricardo Gazzola Zen ◽  
...  

Global Heart ◽  
2017 ◽  
Vol 12 (2) ◽  
pp. 115 ◽  
Author(s):  
Ambroise Wonkam ◽  
Ricardo Toko ◽  
David Chelo ◽  
Cedrik Tekendo-Ngongang ◽  
Samuel Kingue ◽  
...  

2011 ◽  
Vol 57 (1) ◽  
pp. 62-65 ◽  
Author(s):  
Rafael Fabiano Machado Rosa ◽  
Patrícia Trevisan ◽  
Dayane Bohn Koshiyama ◽  
Carlo Benatti Pilla ◽  
Paulo Ricardo Gazzola Zen ◽  
...  

2020 ◽  
Vol 2020 ◽  
pp. 1-6
Author(s):  
Sathiya Maran ◽  
Siti Aisyah Faten ◽  
Swee-Hua Erin Lim ◽  
Kok-Song Lai ◽  
Wan Pauzi Wan Ibrahim ◽  
...  

Background. The 22q11.2 deletion syndrome (22q11.2DS) is the most common form of deletion disorder in humans. Low copy repeats flanking the 22q11.2 region confers a substrate for nonallelic homologous recombination (NAHR) events leading to rearrangements which have been reported to be associated with highly variable and expansive phenotypes. The 22q11.2DS is reported as the most common genetic cause of congenital heart defects (CHDs). Methods. A total of 42 patients with congenital heart defects, as confirmed by echocardiography, were recruited. Genetic molecular analysis using a fluorescence in situ hybridization (FISH) technique was conducted as part of routine 22q11.2DS screening, followed by multiplex ligation-dependent probe amplification (MLPA), which serves as a confirmatory test. Results. Two of the 42 CHD cases (4.76%) indicated the presence of 22q11.2DS, and interestingly, both cases have conotruncal heart defects. In terms of concordance of techniques used, MLPA is superior since it can detect deletions within the 22q11.2 locus and outside of the typically deleted region (TDR) as well as duplications. Conclusion. The incidence of 22q11.2DS among patients with CHD in the east coast of Malaysia is 0.047. MLPA is a scalable and affordable alternative molecular diagnostic method in the screening of 22q11.2DS and can be routinely applied for the diagnosis of deletion syndromes.


2020 ◽  
Vol 09 (04) ◽  
pp. 227-234
Author(s):  
Bruna Lixinski Diniz ◽  
Andressa Schneiders Santos ◽  
Andressa Barreto Glaeser ◽  
Bruna Baierle Guaraná ◽  
Cláudia Fernandes Lorea ◽  
...  

Abstract22q11.2 deletion syndrome (22q11.2DS) is considered one of the most frequently observed chromosomal abnormalities in association with congenital heart disease (CHD), which can also include some combination of other features. Thus, the aim of this work was to verify the profile of dysmorphic features and heart defects found in patients referred to a reference center in Southern Brazil with clinical findings suggestive of 22q11.2DS. In the overall sample group, only patients with dysmorphic facial features (skull, eyes, ear, and nose) associated with CHD (obstructive pulmonary valve ring, truncus arteriosus, and bicuspid aortic valve associated with atrial septal defect and/or right aortic arch) had a 22q11.2 deletion. These findings proved to be reliable clinical criteria for referral to perform fluorescent in situ hybridization investigation for 22q11.2 deletion.


2010 ◽  
Vol 28 (5) ◽  
pp. 287-292 ◽  
Author(s):  
Valentina Guida ◽  
Francesca Lepri ◽  
Raymon Vijzelaar ◽  
Andrea De Zorzi ◽  
Paolo Versacci ◽  
...  

GATA4mutations are found in patients with different isolated congenital heart defects (CHDs), mostly cardiac septal defects and tetralogy of Fallot. In addition,GATA4is supposed to be the responsible gene for the CHDs in the chromosomal 8p23 deletion syndrome, which is recognized as a malformation syndrome with clinical symptoms of facial anomalies, microcephaly, mental retardation, and congenital heart defects. Thus far, no study has been carried out to investigate the role ofGATA4copy number variations (CNVs) in non-syndromic CHDs. To explore the possible occurrence ofGATA4gene CNVs in isolated CHDs, we analyzed by multiplex ligation-dependent probe amplification (MLPA) a cohort of 161 non-syndromic patients with cardiac anomalies previously associated withGATA4gene mutations. The patients were mutation-negative forGATA4,NKX2.5, andFOG2genes after screening with denaturing high performance liquid chromatography. MLPA analysis revealed that normalized MLPA signals were all found within the normal range values for all exons in all patients, excluding a major contribution ofGATA4gene CNVs in CHD pathogenesis.


2016 ◽  
Vol 371 (1710) ◽  
pp. 20150406 ◽  
Author(s):  
Jason R. Cowan ◽  
Muhammad Tariq ◽  
Chad Shaw ◽  
Mitchell Rao ◽  
John W. Belmont ◽  
...  

Genomic disorders and rare copy number abnormalities are identified in 15–25% of patients with syndromic conditions, but their prevalence in individuals with isolated birth defects is less clear. A spectrum of congenital heart defects (CHDs) is seen in heterotaxy, a highly heritable and genetically heterogeneous multiple congenital anomaly syndrome resulting from failure to properly establish left–right (L-R) organ asymmetry during early embryonic development. To identify novel genetic causes of heterotaxy, we analysed copy number variants (CNVs) in 225 patients with heterotaxy and heterotaxy-spectrum CHDs using array-based genotyping methods. Clinically relevant CNVs were identified in approximately 20% of patients and encompassed both known and putative heterotaxy genes. Patients were carefully phenotyped, revealing a significant association of abdominal situs inversus with pathogenic or likely pathogenic CNVs, while d-transposition of the great arteries was more frequently associated with common CNVs. Identified cytogenetic abnormalities ranged from large unbalanced translocations to smaller, kilobase-scale CNVs, including a rare, single exon deletion in ZIC3, a gene known to cause X-linked heterotaxy. Morpholino loss-of-function experiments in Xenopus support a role for one of these novel candidates, the platelet isoform of phosphofructokinase-1 ( PFKP ) in heterotaxy. Collectively, our results confirm a high CNV yield for array-based testing in patients with heterotaxy, and support use of CNV analysis for identification of novel biological processes relevant to human laterality. This article is part of the themed issue ‘Provocative questions in left–right asymmetry’.


Sign in / Sign up

Export Citation Format

Share Document